S'abonner

Second-trimester cardiovascular biometry in growth-restricted fetuses; a multicenter cohort study - 29/06/22

Doi : 10.1016/j.ajog.2021.12.031 
Julie Spang Frandsen, MD a, b, , Kasper Gadsbøll, MD a, b, Finn Stener Jørgensen, MD, DMSc b, c, Olav Bjørn Petersen, MD, PhD a, b, Line Rode, MD, PhD d, Karin Sundberg, MD, DMSc a, Helle Zingenberg, MD e, Ann Tabor, MD, DMSc a, b, Charlotte Kvist Ekelund, MD, PhD a, b, Cathrine Vedel, MD, PhD a
a Center of Fetal Medicine and Pregnancy, Department of Obstetrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark 
b Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark 
c Fetal Medicine Unit, Department of Obstetrics and Gynecology, Copenhagen University Hospital Hvidovre, Copenhagen, Denmark 
d Department of Clinical Biochemistry, Copenhagen University Hospital Rigshospitalet, Glostrup, Copenhagen, Denmark 
e Department of Obstetrics and Gynecology, Copenhagen University Hospital Herlev, Herlev, Denmark 

Corresponding author: Julie Spang Frandsen, MD.

Abstract

Background

Intrauterine growth restriction is associated with an increased risk of cardiovascular changes neonatally. However, the underlying pathways are poorly understood, and it is not clear whether the dysfunction is already present in the fetus.

Objective

This study aimed to investigate fetal cardiac dimensions assessed from images at the second trimester anatomy scan from fetuses classified postnatally as small for gestational age and intrauterine growth restricted and compare them with appropriate for gestational age fetuses.

Study Design

This was a substudy from The Copenhagen Baby Heart Study, a prospective, multicenter cohort study including fetuses from the second trimester of pregnancy in Copenhagen from April 2016 to October 2018. The mothers were recruited at the second trimester anatomy scan that included extended cardiovascular image documentation followed by consecutively measured heart biometry by 2 investigators blinded for the pregnancy outcome. The fetuses were classified postnatally as small for gestational age and intrauterine growth restricted according to the International Society of Ultrasound in Obstetrics and Gynecology 2020 guidelines using birthweight and with a retrospective assessment of Doppler flow. The mean differences in the cardiovascular biometry were adjusted for gestational age at the time of the second trimester scan and the abdominal circumference. The z-scores were calculated, and the comparisons were Bonferroni corrected (significance level of P<.005). Receiver operating characteristic curves were computed after performing backward regression on several maternal characteristics and biomarkers.

Results

We included 8278 fetuses, with 625 (7.6%) of them being small for gestational age and 289 (3.5%) being intrauterine growth restricted. Both small for gestational age and intrauterine growth restricted fetuses had smaller heart biometry, including the diameter at the location of the aortic valve (P<.005), the ascending aorta in the 3-vessel view (P<.005), and at the location of the pulmonary valve (P<.005). The intrauterine growth restricted group had significantly smaller hearts with respect to length and width (P<.005) and smaller right and left ventricles (P<.005). After adjusting for the abdominal circumference, the differences in the aortic valve and the pulmonary valve remained significant in the intrauterine growth restricted group. Achievement of an optimal receiver operating characteristic curve included the following parameters: head circumference, abdominal circumference, femur length, gestational age, pregnancy associated plasma protein-A multiples of median, nullipara, spontaneous conception, smoking, body mass index <18.5, heart width, and pulmonary valve with an area under the curve of 0.91 (0.88–0.93) for intrauterine growth restricted cases.

Conclusion

Intrauterine growth restricted fetuses had smaller prenatal cardiovascular biometry, even when adjusting for abdominal circumference. Our findings support that growth restriction is already associated with altered cardiac growth at an early stage of pregnancy. The heart biometry alone did perform well as a screening test, but combined with other factors, it increased the sensitivity and specificity for intrauterine growth restriction.

Le texte complet de cet article est disponible en PDF.

Key words : cardiovascular biometry, cardiovascular programming, fetal growth restriction, prenatal ultrasound, second trimester, small for gestational age


Plan


 O.B.P. holds a professorship funded by the Novo Nordisk Foundation; grant NNFSA170030576. None of the other authors report any conflict of interest concerning the content of this manuscript.
 C.V. received funding from the “Rigshospitalets Research Foundation” and the “Aase and Ejnar Danielsens Research Foundation” to carry out the study.
 Cite this article as: Frandsen JS, Gadsbøll K, Jørgensen FS, et al. Second-trimester cardiovascular biometry in growth-restricted fetuses; a multicenter cohort study. Am J Obstet Gynecol 2022;227:81.e1-13.


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 227 - N° 1

P. 81.e1-81.e13 - juillet 2022 Retour au numéro
Article précédent Article précédent
  • Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome
  • Pe’er Dar, Bo Jacobsson, Rebecca Clifton, Melissa Egbert, Fergal Malone, Ronald J. Wapner, Ashley S. Roman, Asma Khalil, Revital Faro, Rajeevi Madankumar, Lance Edwards, Noel Strong, Sina Haeri, Robert Silver, Nidhi Vohra, Jon Hyett, Zachary Demko, Kimberly Martin, Matthew Rabinowitz, Karen Flood, Ylva Carlsson, Georgios Doulaveris, Sean Daly, Maria Hallingström, Cora MacPherson, Charlly Kao, Hakon Hakonarson, Mary E. Norton
| Article suivant Article suivant
  • Mid-trimester uterine electromyography in patients with a short cervix
  • Ponnila S. Marinescu, Roger C. Young, Lauren A. Miller, Jesse R. Llop, Eva K. Pressman, Neil S. Seligman

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.